RxDoctor Payments Data

Samir Jani

Pain Medicine · Whiting, NJNPI 1184912826

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (46.2%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Medtronic at 59.7% of the total. Reporting peaked in 2019 at $3,537 and has fallen 99.5% since, to $18 in 2025.

$9,736in general payments, 2019–2025

Across 144 payments — averaging $67.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$6K
  • Abbott$1K
  • Relievant Medsystems, Inc.$670
  • Foundation Fusion Solutions, LLC$290
  • Vertos Medical, Inc.$230
  • Axonics, Inc.$217
  • plus $1K from 9 others
$960in research payments, 2019–2025

Across 2 payments — averaging $480.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$960

What the payments were for

  • Consulting fees$8258%
  • Speaking & faculty fees$4,00041%
  • Travel & lodging$3974%
  • Food & beverage$4,50246%
  • Education$120%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,736 in reported general payments places this provider in the 85th percentile of 256 pain medicine providers in New Jersey.

See all pain medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$1,220,759
Medicare patients
885
Services billed
45,347

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl133$75,010
PercocetOxycodone Hcl/Acetaminophen16$68,080
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,064$34,933
Xtampza ErOxycodone Myristate55$30,968
Lidocaine121$16,052
Buprenorphine37$13,953
Oxycodone Hcl577$12,761
Fentanyl133$11,056
LyricaPregabalin11$9,642
Pregabalin271$7,460
Morphine Sulfate ErMorphine Sulfate195$7,107
Gabapentin407$6,742
MovantikNaloxegol Oxalate15$6,439
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen246$6,301
Hysingla ErHydrocodone Bitartrate12$6,092

Paid to pharmacies, not to this prescriber.

Other pain medicine in Whiting

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →